XSESC8R
Market cap41mUSD
Dec 23, Last price
0.03SGD
1D
0.00%
1Q
7.69%
Jan 2017
133.33%
IPO
-95.66%
Name
Jiutian Chemical Group Ltd
Chart & Performance
Profile
Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a chemical feedstock in the organic chemical industry used in various areas, such as agricultural chemicals, medicines, fuels, synthetic resins, and leather making, as well as in the production of the solvent used for chemical fibers, activating agents, and photography. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; Oxygen-18, an isotope of oxygen to produce fluorodeoxyglucose; deuterium depleted water to inhibit cancer growth; and industrial methanol. In addition, the company is involved in the sale of downstream products; and research and development of isotope technology. Jiutian Chemical Group Limited was founded in 1994 and is based in Singapore.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 598,563 -75.42% | 2,434,843 12.03% | 2,173,310 89.60% | |||||||
Cost of revenue | 907,826 | 1,789,189 | 1,556,575 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (309,263) | 645,654 | 616,735 | |||||||
NOPBT Margin | 26.52% | 28.38% | ||||||||
Operating Taxes | (195) | 181,621 | 160,658 | |||||||
Tax Rate | 28.13% | 26.05% | ||||||||
NOPAT | (309,068) | 464,033 | 456,077 | |||||||
Net income | (344,643) -170.26% | 490,497 50.97% | 324,901 87.06% | |||||||
Dividends | (111,858) | (84,367) | (33,432) | |||||||
Dividend yield | 216.36% | 52.38% | 22.12% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 199,874 | 84,702 | 178,241 | |||||||
Long-term debt | 66,010 | 49,940 | 49,940 | |||||||
Deferred revenue | 2,000 | 2,000 | ||||||||
Other long-term liabilities | ||||||||||
Net debt | (263,736) | (972,981) | (545,369) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (385,651) | 434,006 | 655,814 | |||||||
CAPEX | (125,578) | (9,961) | (22,272) | |||||||
Cash from investing activities | (125,702) | (9,853) | (27,675) | |||||||
Cash from financing activities | (732) | (95,520) | (110,890) | |||||||
FCF | (579,019) | 471,958 | 210,520 | |||||||
Balance | ||||||||||
Cash | 529,620 | 1,107,623 | 773,550 | |||||||
Long term investments | ||||||||||
Excess cash | 499,692 | 985,881 | 664,884 | |||||||
Stockholders' equity | 655,131 | 1,110,243 | 765,801 | |||||||
Invested Capital | 532,029 | 281,664 | 229,484 | |||||||
ROIC | 181.57% | 106.36% | ||||||||
ROCE | 50.67% | 68.44% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 1,988,444 | 1,988,444 | 1,988,444 | |||||||
Price | 0.03 -67.90% | 0.08 6.58% | 0.08 -7.32% | |||||||
Market cap | 51,700 -67.90% | 161,064 6.58% | 151,122 -0.33% | |||||||
EV | (212,036) | (813,306) | (396,512) | |||||||
EBITDA | (286,083) | 667,966 | 645,714 | |||||||
EV/EBITDA | 0.74 | |||||||||
Interest | 1,983 | 2,299 | 3,666 | |||||||
Interest/NOPBT | 0.36% | 0.59% |